Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to $10.9 million.

  • Orthopediatrics' Other Accumulated Expenses rose 3173.8% to $10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.9 million, marking a year-over-year increase of 3173.8%. This contributed to the annual value of $9.7 million for FY2024, which is 3068.6% up from last year.
  • Orthopediatrics' Other Accumulated Expenses amounted to $10.9 million in Q3 2025, which was up 3173.8% from $11.8 million recorded in Q2 2025.
  • In the past 5 years, Orthopediatrics' Other Accumulated Expenses ranged from a high of $11.8 million in Q2 2025 and a low of $1.5 million during Q3 2021
  • Its 5-year average for Other Accumulated Expenses is $6.0 million, with a median of $5.4 million in 2023.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first crashed by 6783.35% in 2021, then skyrocketed by 15744.54% in 2022.
  • Orthopediatrics' Other Accumulated Expenses (Quarter) stood at $2.0 million in 2021, then soared by 145.98% to $5.0 million in 2022, then skyrocketed by 47.29% to $7.4 million in 2023, then soared by 30.69% to $9.7 million in 2024, then rose by 12.85% to $10.9 million in 2025.
  • Its Other Accumulated Expenses stands at $10.9 million for Q3 2025, versus $11.8 million for Q2 2025 and $10.5 million for Q1 2025.